ストックスクリーナーアプリを入手
241.89
0.57%
-1.39
アフターアワーズ：
241.89
Quest Diagnostics Inc (DGX) 最新ニュース
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market - Zacks Investment Research
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates - Zacks Investment Research
Quest Diagnostics (DGX): Is Rapid Test Growth Translating Into Better Customer Economics? - Yahoo Finance
Waters, Quest Diagnostics Collaborate to Expand Access to At-Home HPV Screening for Cervical Cancer - marketscreener.com
Quest Diagnostics Inc expected to post earnings of $2.86 a shareEarnings Preview - TradingView
Quest Diagnostics, Waters plan at-home HPV access in 2027 | DGX Stock News - Stock Titan
A new at-home HPV test kit is going national through Quest Diagnostics - Fast Company
Quest Diagnostics Slides as Investors Weigh Medicare Lab Payment Cut Risk - Quiver Quantitative
UBS Raises Quest Diagnostics Price Target to $250 From $245, Maintains Neutral Rating - marketscreener.com
Current guidelines may miss half of people with a hormone disorder tied to high blood pressure. - Stock Titan
DGX4807226 Bond Profile: Coupon and Redemption - TradingView
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics Incorporated (DGX) Options ChainYahoo Finance - Yahoo! Finance Canada
Quest Diagnostics Incorporated (DGX) Options ChainYahoo Finance - Yahoo! Finance Canada
Quest Diagnostics Incorporated (DGX) Options ChainYahoo Finance - Yahoo! Finance Canada
Quest Diagnostics Incorporated (DGX) Stock forecasts - Yahoo Finance UK
Quest Diagnostics shares may shift 4.4% on Oct. 22 earnings - Investing.com
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Continues to Enjoy a Narrow Moat Thanks to Its Status as Low-Cost Producer - Morningstar
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo! Finance Canada
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings - Zacks Investment Research
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings - TradingView
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings - Yahoo Finance
Quest Diagnostics (NYSE:DGX): A Dividend Quality Pick for Income Investors - ChartMill
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Leerink Partners Adjusts Quest Diagnostics Price Target to $265 From $254 - www.marketscreener.com
Quest Diagnostics Incorporated (DGX) options chain - Yahoo Finance UK
Quest Diagnostics (DGX) Announces Executive Leadership Transitio - GuruFocus
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Catherine T. Doherty to Transition to EVP at Quest Diagnostics, Retirement Set for July 2027 - TradingView
Barclays Adjusts Price Target on Quest Diagnostics to $260 From $250, Keeps Overweight Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Quest Diagnostics to $235 From $240, Keeps In Line Rating - www.marketscreener.com
Quest Diagnostics Inc's Dividend Analysis - Yahoo Finance
Quest Diagnostics (NYSE:DGX) Rides Steady Testing Demand - Kalkine Media
Quest Diagnostics’ Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus - Zacks Investment Research
DGX5874579 Bond Profile: Coupon and Redemption - TradingView
Three Days Left To Buy Quest Diagnostics Incorporated (NYSE:DGX) Before The Ex-Dividend Date - Moomoo
Quest Diagnostics (NYSE:DGX) Breakout Setup Backed by Technical Rating 7 and Setup Rating 8 - ChartMill
Quest Diagnostics (DGX) Highlights Haystack MRD Test Accuracy in Colorectal Cancer Trials - GuruFocus
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally? - TradingView
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally? - Yahoo Finance
Global Paternity & Relationship Testing Services Market Set for Growth Through 2030 as DNA Testing Demand Expands Across Applications and Product Segments - GlobeNewswire Inc.
Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch - Yahoo Finance
Quest Diagnostics shows growth potential despite Medicare uncertainties, driven by testing demand and acquisitions. - Pluang
Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds - Seeking Alpha
3.77%
0.85%
大文字化:
|
ボリューム (24 時間):